Patents by Inventor Nathanael J. Barree

Nathanael J. Barree has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220404354
    Abstract: The invention encompasses a real time, point of care, diagnostic system, including a lateral flow test cassette, a data reader, and an application for processing test results and methods of diagnosis of a disease or virus.
    Type: Application
    Filed: May 6, 2022
    Publication date: December 22, 2022
    Inventors: Andrew ROBINSON, Krishna KOWLGI, Stephen SQUIRES, Brent Wade FERGUSON, Nathanael J. BARREE
  • Publication number: 20220349883
    Abstract: The present invention encompasses a diagnostic test and method to authenticate the veracity of a vaccine. The diagnostic test and method are especially useful in a specific and sensitive immunochromatographic assay, performable within about 15 minutes for the authentication, validation, and veracity of a vaccine, such as a COVID-19 vaccine, in a vial prior to administration to a human.
    Type: Application
    Filed: November 22, 2021
    Publication date: November 3, 2022
    Inventors: Andrew ROBINSON, Krishna Kowlgi, Stephen Squires, Brent Wade Ferguson, Nathanael J. Barree
  • Publication number: 20220349884
    Abstract: The present invention encompasses a diagnostic test and method to authenticate the veracity of a vaccine. The diagnostic test and method are especially useful in a specific and sensitive immunochromatographic (“ICT”) assay, performable within about 15 minutes, for the authentication, validation, and veracity of a vaccine in a vial prior to administration to a human, such as a COVID-19 vaccine.
    Type: Application
    Filed: May 3, 2022
    Publication date: November 3, 2022
    Inventors: Andrew ROBINSON, Krishna KOWLGI, Stephen SQUIRES, Brent Wade FERGUSON, Nathanael J. BARREE
  • Patent number: 11209428
    Abstract: The present invention encompasses a diagnostic test and method to authenticate the veracity of a vaccine. The diagnostic test and method are especially useful in a specific and sensitive immunochromatographic assay, performable within about 15 minutes for the authentication, validation, and veracity of a vaccine, such as a COVID-19 vaccine, in a vial prior to administration to a human.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: December 28, 2021
    Assignee: Quantum Materials Corporation
    Inventors: Andrew Robinson, Krishna Kowlgi, Stephen Squires, Brent Wade Ferguson, Nathanael J. Barree